Tecrea Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tecrea Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11292
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tecrea Ltd (Tecrea) is a cell and tissue delivery technology for research and drug development applications. The company develops Nanocin reagents and ingredients support research and development in academic and industrial research labs. It develops Nanocin-plasmid and Nanocin-RNA kits that empower transfection of nucleic acids into a wide range of cell types. Tecrea also develops Nanocin-PRO kits that delivers proteins and peptides; Nanocin-SM kits that enable effective delivery of small molecules. The company partners with government, academic and industrial partners to study nanoparticle formation and cell and tissue delivery mechanisms. Tecrea is headquartered in London, the UK.

Tecrea Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecrea Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tecrea Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Toleranzia Enters into Agreement with Tecrea 10
Enzo Life Sciences Enters into Distribution Agreement with Tecrea 11
Sanbio Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 12
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 13
Licensing Agreements 14
Tecrea Enters into Licensing Agreement with Blueberry Therapeutics for Nanocin 14
Tecrea Ltd – Key Competitors 15
Tecrea Ltd – Key Employees 16
Tecrea Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Tecrea Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecrea Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecrea Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Toleranzia Enters into Agreement with Tecrea 10
Enzo Life Sciences Enters into Distribution Agreement with Tecrea 11
Sanbio Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 12
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 13
Tecrea Enters into Licensing Agreement with Blueberry Therapeutics for Nanocin 14
Tecrea Ltd, Key Competitors 15
Tecrea Ltd, Key Employees 16

List of Figures
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tecrea Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informat …
  • OUTsurance Holdings Limited:企業の戦略・SWOT・財務情報
    OUTsurance Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary OUTsurance Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Finance Wales plc:企業のM&A・事業提携・投資動向
    Finance Wales plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finance Wales plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Veolia Environnement SA (VIE)-エネルギー分野:企業M&A・提携分析
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • Ominto Inc:企業の戦略的SWOT分析
    Ominto Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Duravit AG:企業の戦略・SWOT・財務情報
    Duravit AG - Strategy, SWOT and Corporate Finance Report Summary Duravit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • BOE Technology Group Co Ltd:企業の戦略・SWOT・財務情報
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • DxTerity Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis and monitoring in its genomics laboratory. The company’s patient clinical research platform and dxcollect fingerstick collectio …
  • Unilever Ghana Ltd.:企業の戦略・SWOT・財務分析
    Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report Summary Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • GlycoMimetics Inc (GLYC):企業の財務・戦略的SWOT分析
    GlycoMimetics Inc (GLYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • QBE Insurance Group Limited:企業のM&A・事業提携・投資動向
    QBE Insurance Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QBE Insurance Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Cardinal Health Inc (CAH):医療機器:M&Aディール及び事業提携情報
    Summary Cardinal Health Inc (Cardinal Health) is a company that provides integrated healthcare services and products. It distributes branded and generic drugs; and specialty medicines; over-the-counter healthcare and consumer products; medical equipment; surgical devices; and laboratory products. It …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie) is a chemical company that manufactures and markets high performance polymers and specialty chemicals. The company's products include bonding products, polyamides, damping systems, sealants, coating products, thermoplastic material, technical fibers, and te …
  • Intersnack Group GmbH & Co. KG:企業の戦略・SWOT・財務情報
    Intersnack Group GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Intersnack Group GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Titan Pharmaceuticals Inc (TTNP):企業の財務・戦略的SWOT分析
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • Aeroport Anapa OAO:戦略・SWOT・企業財務分析
    Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bracco SpA:企業の戦略的SWOT分析
    Bracco SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Adamis Pharmaceuticals Corp (ADMP):医療機器:M&Aディール及び事業提携情報
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Trican Well Service Ltd. (TCW)-石油・ガス分野:企業M&A・提携分析
    Summary Trican Well Service Ltd. (Trican) is an oilfield services company, which provides a range of specialized products, equipment, services and technology for use in the drilling, completion, stimulation and reworking of oil and gas wells. Its specialized services comprise fracturing, cementing, …
  • Delta Apparel, Inc. (DLA):企業の財務・戦略的SWOT分析
    Delta Apparel, Inc. (DLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆